| Followers | 827 |
| Posts | 119559 |
| Boards Moderated | 15 |
| Alias Born | 09/05/2002 |
Sunday, February 02, 2014 5:11:57 PM
Phase-3 Datasets for ABBV/ENTA vs GILD
You be the judge!
ABBV/ENTA (6 phase-3 trials; 2,053 patients):
GILD (3 phase-3 trials; 1,952 patients):
You be the judge!
ABBV/ENTA (6 phase-3 trials; 2,053 patients):
GILD (3 phase-3 trials; 1,952 patients):
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
